INNOVATE Corp. (VATE)
5.80
-0.10 (-1.69%)
At close: Apr 17, 2025, 3:59 PM
5.80
0.00%
After-hours: Apr 17, 2025, 04:09 PM EDT
-1.69% (1D)
| Bid | 5.2 |
| Market Cap | 77.04M |
| Revenue (ttm) | 1.11B |
| Net Income (ttm) | -34.9M |
| EPS (ttm) | -3.08 |
| PE Ratio (ttm) | -1.88 |
| Forward PE | 0.16 |
| Analyst | n/a |
| Ask | 6.19 |
| Volume | 7,454 |
| Avg. Volume (20D) | 638,888 |
| Open | 6.03 |
| Previous Close | 5.90 |
| Day's Range | 5.65 - 6.03 |
| 52-Week Range | 3.25 - 13.79 |
| Beta | 2.25 |
About VATE
INNOVATE Corp., through its subsidiaries, operates in infrastructure, life sciences, and spectrum areas in the United States. It provides industrial construction, structural steel, and facility maintenance services for use in commercial, industrial, and infrastructure construction projects, such as buildings and office complexes, hotels and casinos, convention centers, sports arenas and stadiums, shopping malls, hospitals, dams, bridges, mines, m...
Industry Engineering & Construction
Sector Industrials
IPO Date Jul 13, 2009
Employees 3,135
Stock Exchange NYSE
Ticker Symbol VATE
Website https://www.innovatecorp.com
1 month ago
-12.26%
Shares of companies in the broader industrial sect...
Unlock content with
Pro Subscription
2 months ago
+86.3%
INNOVATE Corp shares are trading higher after the company announced on Friday that it received FDA approval for its TGFR System for accurate kidney function testing.
